[Protease inhibitors].
D000328:Adult; D000990:Antithrombin III / Q000378:metabolism; D001777:Blood Coagulation; D002918:Chymotrypsin / Q000037:antagonists & inhibitors; D003174:Complement C1 Inactivator Proteins / Q000378:metabolism; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D010641:Phenotype; D011110:Polymorphism, Genetic; D011480:Protease Inhibitors / Q000378:metabolism; D014361:Trypsin Inhibitors / Q000378:metabolism; D000515:alpha 1-Antitrypsin / Q000235:genetics / Q000378:metabolism; D000979:alpha-2-Antiplasmin / Q000378:metabolism; D000511:alpha-Macroglobulins / Q000235:genetics / Q000378:metabolism
D003174:Complement C1 Inactivator Proteins; D011480:Protease Inhibitors; D014361:Trypsin Inhibitors; D000515:alpha 1-Antitrypsin; D000979:alpha-2-Antiplasmin; D000511:alpha-Macroglobulins; D000990:Antithrombin III; D002918:Chymotrypsin
Les antiprotéinases.